HIV Seroprevalence among Women Opting Out of Prenatal HIV Screening in Alberta, Canada: 2002-2004
Authors:
Open Access
- 15 December 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (12) , 1640-1643
Abstract
Alberta, Canada, uses an “opt-out” strategy for prenatal HIV testing. We examined demographic characteristics of and HIV seroprevalence among women opting out. The proportion of total specimens that were from women who opted out decreased from 4.3% in 2002 to 3.6% in 2004 (P < .001), and HIV seroprevalence among these specimens was 0.07%, which was 3.3 times higher than the HIV seroprevalence among specimens from women who opted in. Women opting out may have a higher HIV infection risk.Keywords
This publication has 6 references indexed in Scilit:
- Changing the Paradigm for HIV Testing — The End of ExceptionalismNew England Journal of Medicine, 2006
- Potential Factors That May Affect Acceptance of Routine Prenatal HIV TestingCanadian Journal of Public Health, 2005
- FACTORS THAT CONTRIBUTE TO WOMEN DECLINING ANTENATAL HIV TESTINGHealth Care for Women International, 2003
- Trends in HIV Testing Among Pregnant Women: United States, 1994–1999American Journal of Public Health, 2001
- What do pregnant women think about the HIV test? A qualitative studyAIDS Care, 1999
- Human Immunodeficiency Virus Test Refusal in Pregnancy: A Challenge to Voluntary TestingObstetrics & Gynecology, 1998